More than 80% of patients with newly diagnosed rheumatoid arthritis, who were using bridging therapy, successfully tapered ...

Researchers aimed to assess prednisolone discontinuation within 3 months of a short-term bridging regimen in patients with newly diagnosed RA managed with a treat‑to‑target approach. A total of 227 ...

Glucocorticoids are often used as short-term “bridging therapy” when starting disease-modifying antirheumatic drugs (DMARDs) in early rheumatoid arthritis (RA) to rapidly cont ...

Please provide your email address to receive an email when new articles are posted on . Relapse/treatment failure rates did not differ between a low and high dose of prednisolone. The higher dose did ...

PORTLAND, Ore.--(BUSINESS WIRE)--Sparrow Pharmaceuticals, an emerging, clinical-stage biopharmaceutical company developing novel, targeted therapies to address unmet needs in both rheumatology and ...

Less treatment with biologics, 5-aminosalisylic acids, and immunomodulators is associated with higher frailty risk among older adults with IBD. Older adults with inflammatory bowel disease (IBD) ...